Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.8%

2 terminated out of 42 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

36%

15 trials in Phase 3/4

Results Transparency

9%

2 of 22 completed with results

Key Signals

2 with results92% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (12)
Early P 1 (1)
P 2 (3)
P 3 (6)
P 4 (9)

Trial Status

Completed22
Unknown11
Recruiting3
Not Yet Recruiting2
Withdrawn2
Terminated2

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 22 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT07449052Not ApplicableNot Yet Recruiting

Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease

NCT04938661Not ApplicableCompleted

Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)

NCT07378228Not ApplicableCompleted

Weak Pulse at Yang and Wiry Pulse at Yin Theory

NCT07063147Recruiting

TTE Improves Clinical Management of Stable Chest Pain

NCT06606821Phase 4Recruiting

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

NCT06945094Not Yet Recruiting

A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.

NCT05347069Phase 4RecruitingPrimary

Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization

NCT03341663CompletedPrimary

The Diagnostic Value of Acupoint Sensitization Based on Stable Angina Pectoris

NCT02165670Withdrawn

BASIC VALIDATE Coronary Stent Registry

NCT04575207Not ApplicableUnknown

The Flash FFR Ⅱ Study

NCT04465669Not ApplicableCompleted

Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation

NCT02747329Not ApplicableCompleted

A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT

NCT02029118Early Phase 1CompletedPrimary

Acupoint Application in Patients With Stable Angina Pectoris (AASAP)

NCT00825604Phase 2WithdrawnPrimary

Quality of Life and Target Achievement After Treatment of Patients With Stable Angina Pectoris

NCT03794713Not ApplicableUnknown

A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)

NCT02328898Phase 4UnknownPrimary

Randomized "All-comer" Evaluation of a Permanent Polymer Resolute Integrity Stent Versus a Polymer Free Cre8 Stent

NCT00352014CompletedPrimary

Evaluation and Comparison of Several Point-of-care Platelet Function Tests in Predicting Clinical Outcomes in Clopidogrel Pre-treated Patients Undergoing Elective PCI.

NCT02339454Phase 3CompletedPrimary

Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris

NCT01453582Phase 3CompletedPrimary

Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris

NCT02176174Completed

Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study

Scroll to load more

Research Network

Activity Timeline